Millennium Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Millennium Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50,000	Closed	-$927K	–	6803
2023 Q3	$927K	Buy	+50,000	New	+$566K	﹤0.01%	4241
2016 Q4	–	Sell	-55,100	Closed	-$9.07M	–	3845
2016 Q3	$9.07M	Sell	55,100 -24,900	-31%	-$3.93M	0.02%	983
2016 Q2	$11.4M	Sell	80,000 -217,400	-73%	-$31.7M	0.03%	781
2016 Q1	$38.2M	Buy	+297,400	New	+$35.1M	0.1%	245
2015 Q1	–	Sell	-70,000	Closed	-$10.9M	–	4234
2014 Q4	$10.9M	Sell	70,000 -10,000	-13%	-$1.85M	0.02%	933
2014 Q3	$18.9M	Buy	+80,000	New	+$20.4M	0.05%	525
2014 Q2	–	Sell	-900	Closed	-$297K	–	4004
2014 Q1	$297K	Buy	+900	New	+$304K	﹤0.01%	2941

Millennium Management's ICPT Position: Q4 2023 in Review

Millennium Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 179,333 shares — an estimated $3.32M sold.

Millennium Management first reported a position in ICPT in Q2 2013 and held it in 35 quarters. The position peaked at $97M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Millennium Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Millennium Management sold 179,333 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $3.32M.
Millennium Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 35 quarters.
Millennium Management's Intercept Pharmaceuticals, Inc. position peaked at $97M in Q1 2015.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.